Welcome!

Visit us at Booth 204 at the 2014 Annual Meeting of
the American College of Toxicology,
November 9-12, Orlando, FL.

ImmunoTox, Inc. specializes in studies evaluating the effects of drugs, chemicals, and physical agents on the immune system.

In Vivo and In Vitro studies are carried out in well-equipped laboratories specifically designed for immunotoxicological studies.

Immunotox®, Inc. is now a division of AIBioTech®. Read about the acquisition.

ImmunoTox® Announces Implementation of Human Immunopharmacology Assays
ImmunoTox®, A Division of American International Biotechnology®, LLC, can now assess the impact on the human immune system of your biologic, test agent, or drug. It is often advantageous to understand the impact of a new analyte on the human immune system before extending a drug development program thought later phases of human clinical testing. Furthermore, in vitro testing can help identify the lead compound or the most potentially successful compound of a series. Read More ...

Vanessa Peachee, Ph.D, Director, ImmunoTox®, to Present Poster at the 2014 Annual Meeting of the American College of Toxicology
Visit ImmunoTox® at Booth 204
Dr. Peachee, Director of ImmunoTox®, will present her poster (#402) "Characterization of T-dependent Antibody Response (TDAR) to Keyhole Limpet Hemocyanin (KLH) in the Göttingen Minipig" at the upcoming American College of Toxicology Annual Meeting, November 9-12, 2014, in Orlando, FL. Read more ...